title: Company restores access to multiple sclerosis drug after pressure from neurologists.
authors: Jeremy
authors: J
authors: Laurance
mesh_terms: D000074323:Alemtuzumab; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D002491:Central Nervous System Agents / Q000600:supply & distribution / Q000627:therapeutic use*; D017277:Drug Approval; D004345:Drug Industry; D006297:Health Services Accessibility; D006801:Humans; D009103:Multiple Sclerosis / Q000188:drug therapy*; D056687:Off-Label Use
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D002491:Central Nervous System Agents; D000074323:Alemtuzumab